Punch & Associates Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-900
Closed -$259K 181
2023
Q4
$259K Hold
900
0.02% 196
2023
Q3
$242K Buy
+900
New +$225K 0.02% 192
2022
Q4
Sell
-1,000
Closed -$225K 225
2022
Q3
$225K Hold
1,000
0.02% 201
2022
Q2
$243K Sell
1,000
-16
-2% -$3.92K 0.02% 204
2022
Q1
$246K Buy
1,016
+16
+2% +$3.68K 0.01% 203
2021
Q4
$225K Hold
1,000
0.01% 211
2021
Q3
$213K Hold
1,000
0.01% 214
2021
Q2
$244K Sell
1,000
-44
-4% -$10.8K 0.01% 212
2021
Q1
$260K Hold
1,044
0.02% 215
2020
Q4
$240K Hold
1,044
0.02% 208
2020
Q3
$265K Hold
1,044
0.02% 209
2020
Q2
$246K Hold
1,044
0.02% 209
2020
Q1
$212K Buy
+1,044
New +$228K 0.03% 202

Other funds holding AMGN

Punch & Associates Investment Management's AMGN Position: Q1 2024 in Review

Punch & Associates Investment Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 900 shares — an estimated $259K sold.

Punch & Associates Investment Management first reported a position in AMGN in Q1 2020 and held it in 13 quarters. The position peaked at $265K in Q3 2020. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Punch & Associates Investment Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Punch & Associates Investment Management sold 900 Amgen shares in Q1 2024, an estimated $259K.
  • Punch & Associates Investment Management first reported a position in Amgen in Q1 2020 and held it in 13 quarters.
  • Punch & Associates Investment Management's Amgen position peaked at $265K in Q3 2020.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Punch & Associates Investment Management's 13F filing for Q1 2024, filed 15 May 2024.